A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Summary

This is Phase 3 study, multi-centre, double-blind, placebo controlled, parallel group to evaluate the effects of AC-SD-03 on the efficacy and safety among participants with mild to moderate Alzheimer's Disease.

Timeline

Start

2022-06-30

Primary completion

2023-12-31

Completion

2024-02-28

Outcome

Outcome not reported

Stopped: “Study replaced with a new study”

Drugs

Indications